My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Novo Nordisk A/S Common Stock (NY:NVO)

47.42 UNCHANGED

Streaming Delayed Price Updated: 7:00 PM EST, Feb 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Novo Nordisk A/S Common Stock

< Previous 1 2

...

25 26 27 28 29 30 31 32 33

...

99 100 Next >

Trump Turns Up Heat On Big Pharma CEOs To Slash Drug Prices Within 60 Days — But Retail Traders Don't Flinch ↗

July 31, 2025

Via Stocktwits

Topics Government

Why Novo Nordisk Stock Crumbled Again Today ↗

July 31, 2025

The company is still being punished for slicing its guidance.

Via The Motley Fool

Securities Fraud Investigation Into Novo Nordisk A/S (NVO) Continues – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm

July 31, 2025

From Glancy Prongay & Murray LLP

Via Business Wire

Eli Lilly Obesity Drug Mounjaro Beats Legacy Trulicity On Cardio-Renal Health ↗

July 31, 2025

Eli Lilly's Mounjaro matched Trulicity in heart outcomes and showed added benefits on A1C, weight, kidney function, and mortality in a major trial.

Via Benzinga

Novo Nordisk, SoFi Tech, PayPal, UnitedHealth, Spotify: Stocks Making The Biggest Moves Today ↗

July 29, 2025

Via Stocktwits

Why Novo Nordisk Stock Plummeted Today ↗

July 30, 2025

Wall Street is reacting with downgrades to Novo's earnings, but with shares trading at their lowest valuation in years, patient investors could find opportunity as the stock falls.

Via The Motley Fool

Topics Stocks

Novo Nordisk A/S (NVO) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

July 30, 2025

From Law Offices of Howard G. Smith

Via Business Wire

Novo Nordisk Hit With Stock Downgrades After Lowering Full-Year Outlook: But Retail Is Optimistic On Company’s Profitability ↗

July 30, 2025

Barclays downgraded Novo to ‘Equal Weight’ from ‘Overweight’ with a price target of DKK 375, down from DKK 700.

Via Stocktwits

This Union Pacific Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday ↗

July 30, 2025

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

July 30, 2025

Via Benzinga

Securities Fraud Investigation Into Novo Nordisk A/S (NVO) Continues – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

July 30, 2025

From The Law Offices of Frank R. Cruz

Via Business Wire

Novo Nordisk Stock Hits New 52-Week Low Amid Profit Warning: What Investors Need To Know ↗

July 30, 2025

Shares of Novo Nordisk are trading lower Wednesday morning. The stock is extending a dramatic sell-off from Tuesday's session.

Via Benzinga

Novo Nordisk Stock Is Plummeting. Time to Panic, or Is This an Opportunity? ↗

July 30, 2025

NVO stock is now down 65% from last year's high.

Via The Motley Fool

Rosen Law Firm Encourages Novo Nordisk A/S Investors to Inquire About Securities Class Action Investigation – NVO

July 30, 2025

From The Rosen Law Firm, P.A.

Via Business Wire

Novo Nordisk Charts Signal Weakness Amid Wegovy Warning, Expert Says 'Could've Played Out VERY Differently If They Had Embraced $HIMS' ↗

July 30, 2025

Novo Nordisk's technical chart is displaying a largely bearish trend amid a profit warning tied to its blockbuster obesity drug Wegovy.

Via Benzinga

Unitedhealth, Starbucks, Novo Nordisk, UPS And Meta: Why These 5 Stocks Are On Investors' Radars Today ↗

July 29, 2025

UNH, SBUX, NVO, UPS, META were among the stocks seen trending on Tuesday, July 29, 2025.

Via Benzinga

Why Eli Lilly Stock Was Looking Sickly Today ↗

July 29, 2025

It seemed the market overreacted to discouraging news from one of the company's rivals.

Via The Motley Fool

History of Novo Nordisk A/S Stock: From Insulin Pioneers to Global Pharma Leader (NYSE:NVO)

July 29, 2025

Novo Nordisk A/S (NYSE:NVO) has evolved over the past century from a humble insulin manufacturer in Denmark into one of the world’s most valuable pharmaceutical companies. With a commanding presence in...

Via MarketMinute

Topics Economy Emissions

Novo Nordisk Shares Plunge Amid Leadership Shakeup (NYSE:NVO)

July 29, 2025

In a surprising turn of events, shares of pharmaceutical giant Novo Nordisk (NYSE:NVO) fell sharply following the company’s announcement of a significant leadership restructuring. The abrupt changes at...

Via MarketMinute

Topics ETFs Economy

Why NovoCure Stock Is Cratering Today ↗

July 29, 2025

The Ozempic maker's stock is dropping fast -- here's why.

Via The Motley Fool

Topics Stocks

AMD Rises To 1-Year Highs, Crude Eyes $68: What's Moving Markets Tuesday? ↗

July 29, 2025

Risk appetite took a breather Tuesday, with major U.S. stock indices retreating modestly from record highs as investors braced for a pivotal stretch of earnings and macro events.

Via Benzinga

Eli Lilly’s Cancer Drug Demonstrates Better Effectiveness Than AbbVie’s In Late Stage Trial: Retail Believes In Holding The Stock ↗

July 29, 2025

Jaypirca had an overall response rate better than AbbVie’s Imbruvica in the study, meaning a higher percentage of patients treated with Jaypirca experienced their cancer shrink or disappear after...

Via Stocktwits

What's Going On With Eli Lilly Stock On Tuesday? ↗

July 29, 2025

Eli Lilly stock slips after Novo Nordisk trims 2025 forecast; Jaypirca meets endpoint in CLL trial against J&J's Imbruvica, with more data expected.

Via Benzinga

Crude Oil Gains Over 1%; UnitedHealth Earnings Miss Views ↗

July 29, 2025

Via Benzinga

Topics Earnings

Novo Nordisk Stock Slumps After Slashing Full-Year Guidance, But Retail Has Its Eyes On An Oral Weight Loss Drug ↗

July 29, 2025

The company now expects full-year sales growth of 8% to 14% at a constant exchange rate, down from its previous estimate of 13% to 21%.

Via Stocktwits

NVO Investors Have Opportunity to Join Novo Nordisk A/S Fraud Investigation with the Schall Law Firm

July 29, 2025

From The Schall Law Firm

Via Business Wire

Novo Nordisk Implodes After Wegovy Warning—Is The Weight-Loss Bubble Bursting? ↗

July 29, 2025

Novo Nordisk stock collapsed 26% in its worst trading day ever after slashing guidance on Wegovy sales and naming a new CEO.

Via Benzinga

Novo Nordisk Falls On Lowered Guidance. Pharma Giant Names New CEO. ↗

July 29, 2025

Novo Nordisk lowered its full-year guidance and named a new CEO. The pharma giant's shares plunged in early trades.

Via Investor's Business Daily

Topics Artificial Intelligence

Ozempic And Wegovy Maker Cuts Outlook In Surprise Move, Picks New CEO ↗

July 29, 2025

Novo Nordisk lowers 2025 guidance as Wegovy and Ozempic face slower U.S. uptake, competition, and continued compounded GLP-1 sales.

Via Benzinga

Stay updated with the stocks that are on the move in today's pre-market session. ↗

July 29, 2025

Before the US market kicks off on Tuesday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.

Via Chartmill

< Previous 1 2

...

25 26 27 28 29 30 31 32 33

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.